Supermarkets are finding the blush of profits associated with the release of prescription to over-the-counter products is short-lived, especially in a competitive category like analgesics. More than one year ago, retailer expectations were high when the analgesics, Orudis KT and Actron, were introduced as OTC medications. They expected another flurry of sales activity would boost their profits and volume in the category. "That has not been the case," said Steve Lauder, health care category ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.